Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aeruginosin 865, a compound extracted from the terrestrial cyanobacterium Nostoc sp. Luke ová 30/93, represents the inaugural aeruginosin-type peptide to incorporate a fatty acid and a carbohydrate moiety. It functions by inhibiting the translocation of NF-kB to the nucleus, thereby exerting an anti-inflammatory effect.
説明 | Aeruginosin 865, a compound extracted from the terrestrial cyanobacterium Nostoc sp. Luke ová 30/93, represents the inaugural aeruginosin-type peptide to incorporate a fatty acid and a carbohydrate moiety. It functions by inhibiting the translocation of NF-kB to the nucleus, thereby exerting an anti-inflammatory effect. |
In vitro | Aeruginosin 865, when pre-treated at concentrations ranging from 0.1 to 100 μg/mL, significantly inhibits IL-8 (EC 50 = 3.5 μg/mL) and ICAM-1 (EC 50 = 50.0 μg/mL) in a concentration-dependent manner in hTNF-α-stimulated HLMVECs, without compromising cell viability in HeLa and HepG2 cells even at much higher concentrations[1]. Furthermore, at concentrations of 100-200 μM, Aeruginosin 865 exhibits cytotoxicity towards Mouse fibrosarcoma cells, while demonstrating no cytotoxic effects on NIH/3T3 cells[2]. |
分子量 | 864.991 |
分子式 | C41H64N6O14 |
CAS No. | 1611990-01-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aeruginosin 865 1611990-01-2 Inhibitor inhibitor inhibit